Browse Related Topics For:

Patents

3952
Patent Litigation
3185
Patent Infringement
1677
Patent Trial and Appeal Board
1549
Inter Partes Review (IPR) Proceeding
1542
USPTO
1246
SCOTUS
1187
Patent-Eligible Subject Matter
1100
Pharmaceutical Industry
1089
Pharmaceutical Patents
917
Appeals
746
America Invents Act
712
Claim Construction
696
Prior Art
643
Patent Applications
577
CLS Bank v Alice Corp
536
Popular
506
Obviousness
477
Intellectual Property Protection
446
Patent Invalidity
375
Generic Drugs
373
Patent Reform
372
Section 101
336
ANDA
335
Trademarks
333
Abstract Ideas
322
FDA
322
Infringement
316
Post-Grant Review
316
Prescription Drugs
302
Covered Business Method Patents
297
Copyright
289
ITC
282
Biotechnology
280
EU
274
Software
265
Biosimilars
240
Patent Trolls
238
Patent-in-Suit
237
BPCIA
237
Mayo v. Prometheus
235
Patent Ownership
234
Design Patent
233
Hatch-Waxman
220
Trade Secrets
217
DNA
217
Myriad
216
Covered Business Method Proceedings
216
Induced Infringement
197
Attorney's Fees
194
Corporate Counsel
191
Life Sciences
184
Venue
179
Inventors
179
IP License
177
Computer-Related Inventions
174
AMP v Myriad
172
Summary Judgment
169
FTC
168
Reversal
167
Personal Jurisdiction
164
TC Heartland LLC v Kraft Foods
156
Australia
156
Damages
150
Amgen
140
Apple
139
Discovery
139
Young Lawyers
135
Indefiniteness
135
Software Patents
134
Motion to Dismiss
133
Inventions
133
Patent Prosecution
133
Willful Infringement
132
Human Genes
132
Technology
131
Octane Fitness v. ICON
131
Patent Exhaustion
129
En Banc Review
129
Medical Devices
128
Sandoz
125
Sandoz v Amgen
125
Standard Essential Patents
123
Estoppel
123
Evidence
121
Standing
119
Jurisdiction
117
Motion to Amend
117
Standard of Review
117
Teva Pharmaceuticals
113
Declaratory Judgments
113
License Agreements
113
Preliminary Injunctions
112
Patent Royalties
112
Principal Place of Business
111
Remand
110
Broadest Reasonable Interpretation Standard
109
Biologics
107
First-to-File
105
Section 337
102
FRAND
100
Alice Corporation
100
Intellectual Property Litigation
100
Non-Practicing Entities
97
UK
95
China
95
Forum Shopping
95
Patent Dance
95
Patent Validity
92
CLS Bank
92
Utility Patents
89
Direct Infringement
89
Expert Testimony
89
Genetic Materials
87
Actavis Inc.
87
Halo v Pulse
87
Patent Term Adjustment
87
Royalties
86
Imports
85
Canada
85
Manufacturers
84
Enhanced Damages
84
Federal Rules of Civil Procedure
84
Nautilus Inc. v. Biosig Instruments
83
Patent Examinations
83
Samsung
82
Laches
81
Apotex
81
Microsoft
80
European Patent Office
79
Google
79
Mylan Pharmaceuticals
79
Teva v Sandoz
78
Apple v Samsung
77
Burden of Proof
76
State of Incorporation
74
Licenses
73
Administrative Proceedings
73
De Novo Standard of Review
73
Novartis
73
Vacated
70
Certiorari
70
Unified Patent Court
69
Proposed Legislation
68
Joinder
68
Myriad-Mayo
68
Reverse Payment Settlement Agreements
67
ALJ
67
Article III
67
Dismissals
66
Impression Products v Lexmark International
66
On-Sale Bar
66
Statute of Limitations
65
Final Written Decisions
64
Innovation Act
64
Limelight v Akamai
64
Misappropriation
64
Petition For Rehearing
64
Written Descriptions
63
Antitrust Litigation
63
FTC v Actavis
62
CAFC
62
Cisco v CommilUSA
62
Patent Filings
62
The Patent Act
61
Breach of Contract
61
Clear Error Standard
61
Noninfringement
61
Notice Requirements
61
Startups
60
Healthcare
60
Highmark v. Allcare
59
Commercial Marketing
59
Exceptional Case
59
Good Faith
59
Judicial Review
58
Ex Partes Reexamination
58
Injunctions
58
Innovation
57
AstraZeneca
57
Inter Partes Reexamination
57
Means-Plus-Function
56
Akamai Technologies
56
Pfizer
56
Preponderance of the Evidence
56
Technology Sector
55
First-to-Invent
55
Markman Hearing
54
Administrative Procedure Act
54
Foreign Sales
54
Patent Assertion Entities
54
Unitary Patent
53
FDA Approval
52
Copyright Infringement
52
Doctrine of Equivalents
52
DOJ
52
Single-Use/No Resale Restriction
51
Pay-For-Delay
51
Preemption
51
Product of Nature Doctrine
51
Real Party in Interest
50
Kimble v Marvel Enterprises
50
Settlement
49
Abuse of Discretion
49
Sequenom
49
Universities
48
Cisco
48
Confidential Information
48
Medtronic
47
Eli Lilly
47
Exports
47
Motion To Stay
47
Patent Cooperation Treaty
47
Smartphones
46
Lanham Act
46
Request for Continued Examination
46
SCA Hygiene Products Aktiebolag v First Quality Baby Products
45
EPO
45
Inequitable Conduct
45
Limelight Networks
45
Patent Portfolios
45
Petition for Writ of Certiorari
45
Sanctions
44
35 U.S.C. § 284
44
Bilski
44
Motorola
43
Component Parts Doctrine
43
European Court of Justice (ECJ)
43
Risk Mitigation
42
Allergan Inc
42
Competition
42
Cuozzo Speed Technologies
42
Guidance Update
42
Hospira
42
UK Brexit
42
USPTO Pilot Program
41
Arbitration
41
Class Action
40
Germany
40
Japan
40
Jury Verdicts
40
Life Technologies Corp v Promega Corp
40
Petrella v. MGM
39
Enfish v Microsoft
39
Expert Witness
39
Genentech
39
Seagate
38
BRCA
38
Constitutional Challenges
38
Cuozzo Speed Technologies v Lee
38
Indirect Infringement
38
Merck
38
Pleading Standards
38
Pleadings
38
Public Comment
38
Sovereign Immunity
38
Watson Pharmaceuticals
37
Divided Infringement
37
Judicial Discretion
37
Oral Argument
37
Sherman Act
36
Brulotte
36
First Sale Doctrine
36
Genetically Engineered Seed
36
Injunctive Relief
36
Patent Prosecution Highway
36
Permanent Injunctions
36
Resales Agreements
36
Stare Decisis
36
Subject Matter Jurisdiction
36
Trademark Registration
35
Abuse of Process
35
Automotive Industry
35
Safe Harbors
35
Software Developers
35
Trademark Infringement
34
AbbVie
34
Chevron Deference
34
Non-Appealable Decisions
34
Orange Book
34
Patent Owner Preliminary Response
34
Reaffirmation
33
Disclosure Requirements
33
Exclusion Orders
33
Extraterritoriality Rules
33
Final Judgment
33
Food Manufacturers
33
Legislative Agendas
33
Litigation Strategies
33
Stream of Commerce
32
aBLA
32
Advertising
32
Bad Faith
32
Method Claims
32
Monsanto
32
Patent Terms
32
Trade Dress
32
Transfer of Venue
32
Validity
32
WIPO
31
Collateral Estoppel
31
Diagnostic Method
31
Examiners
31
First Amendment
31
Foreign Patent Applications
31
Unfair Competition
30
Calculation of Damages
30
Forum Selection
30
Stem cells
29
Attorney-Client Privilege
29
Bowman v Monsanto
29
Counterclaims
29
Defense Strategies
29
Due Process
29
Hague Agreement
29
Hart-Scott-Rodino Act
29
Honest Belief Defense
29
IP Assignment Agreements
29
JMOL
29
Mobile Devices
29
Oil States Energy Services v Greene's Energy Group
29
PATENT Act
29
Pending Legislation
28
Anticipation
28
Defend Trade Secrets Act (DTSA)
28
Equitable Estoppel
28
Kappos
28
Multidistrict Litigation
28
The Copyright Act
27
Amicus Briefs
27
Energy Sector
27
Fee-Shifting
27
Genetic Testing
27
Gilead Sciences
27
Stryker v Zimmer
26
Antitrust Provisions
26
Australian Patent Office
26
Cell Phones
26
Motion for Summary Judgment
25
Acquisitions
25
Administrative Procedure
25
Data Protection
25
Frivolous Lawsuits
25
Gene Patenting
25
Internet
25
Proposed Amendments
25
Provisional Applications
25
Standard of Proof
25
Writ of Mandamus
24
Assignor Estoppel
24
Bayer
24
Burden of Persuasion
24
Enforcement
24
European Commission
24
European Patent Convention
24
Judgment on the Pleadings
24
Kirtsaeng v. John Wiley & Sons
24
Motion To Strike
24
Patent Expiration
24
Plant Patents
24
Public Disclosure
24
Suprema
24
Ultramercial v Hulu
23
ACLU
23
Bristol-Myers Squibb
23
GlaxoSmithKline
23
Hedge Funds
23
Limelight
23
Mootness
23
Research and Development
23
Substantial Evidence Standard
22
3D Printing
22
Antitrust Violations
22
Burden-Shifting
22
Claim Amendments
22
Comment Period
22
Contributory Infringement
22
Depositions
22
Diagnostic Tests
22
Disparagement
22
Eleventh Amendment
22
Federal Rule 12(b)(6)
22
Filing Deadlines
22
Functionality
22
Industrial Design
22
Member State
22
New Legislation
22
Personalized Medicine
22
Reissue Patents
22
SEC
22
Webinars
21
Anti-Competitive
21
Bayh-Dole Act
21
Brooks Furniture
21
Cybersecurity
21
Fashion Industry
21
International Litigation
21
Licensing Rules
21
Mergers
21
New Guidance
21
RAND
21
Rule 11
21
Stays
21
Testimony
21
TRIPS Agreement
21
Twombly/Iqbal Pleading Standard
20
Barack Obama
20
Bascom Global v AT&T Mobility
20
Biologics Price Competition and Innovation Act of 2009
20
Cancer
20
Enablement Inquiries
20
Federal Register
20
Foreign Investment
20
Motion to Compel
20
Non-Disclosure Agreement
20
Nonobvious
20
Par Pharmaceutical
20
Patent Term Extensions
20
Printed Publications
20
Qualcomm
20
Right to a Jury
20
Settlement Agreements
20
Unfair or Deceptive Trade Practices
19
Attorney Malpractice
19
Due Diligence
19
Interference Proceeding
19
Interim Guidance
19
iPhone
19
Issue Preclusion
19
Lost Profits
19
Nintendo
19
Oil & Gas
19
Referendums
19
STRONG Patents Act
19
Telecommunications
19
Trademark Trial and Appeal Board
19
Trans-Pacific Partnership
19
Trump Administration
18
Additional Discovery
18
Business Assets
18
Cross-Border Transactions
18
Definiteness
18
Facebook
18
False Advertising
18
Foreign Corporations
18
Interlocutory Appeals
18
Inventive Concept Test
18
Irreparable Harm
18
Joint Infringement
18
Private Property
18
Protective Orders
18
Section 102
18
Sprint
18
Tariff Act of 1930
18
Websites
17
Affirmative Defenses
17
Biopharmaceutical
17
Cease and Desist Orders
17
Chemicals
17
Commercial Bankruptcy
17
Counterfeiting
17
Derivation Proceeding
17
Domestic Industry Requirement
17
Entrepreneurs
17
Fashion Design
17
International Arbitration
17
Marketing
17
Monopolization
17
New Zealand
17
Prevailing Party
17
Seeds
17
Seventh Amendment
17
Takeda Pharmaceuticals
17
Totality of Circumstances Test
17
Trademark Litigation
17
Treble Damages
17
Uniform Commercial Code (UCC)
17
Venture Capital
17
WTO
16
Amazon
16
Ambry
16
Ariosa
16
Clean Tech
16
Contract Term
16
Declaration
16
Disclosure
16
Dispute Resolution
16
DMCA
16
Double Patent
16
Enforcement Actions
16
Free Speech
16
Inherency
16
Motion to Transfer
16
Patent Agent Privilege
16
Remedies
16
Section 271
16
Small Business
16
Supplemental Evidence
16
Supreme Court of Canada
15
Allergan v Sandoz
15
Brand
15
eBay
15
Employment Contract
15
Endo Pharmaceuticals
15
Exclusive Licenses
15
Fees
15
Generic
15
Janssen Pharmaceuticals
15
Judgment As A Matter Of Law
15
Lexmark
15
Litigation Fees & Costs
15
Medtronic v Boston Scientific
15
Micro Entity Status
15
Myriad v Ambry
15
Patent Fees
15
Priority Patent Claims
14
AFCP
14
Ambiguous
14
Article of Manufacture
14
Burden of Production
14
Cease and Desist
14
CETA
14
Cloud Computing
14
Comcast
14
Confidentiality Agreements
14
Cross Examination
14
Cross-Border
14
Customs
14
E-Commerce
14
Fast Track Process
14
Filing Fees
14
Fraud
14
Innovation Patent
14
Legal Perspectives
14
Likelihood of Confusion
14
Patent Oppositions
14
Proposed Regulation
14
Roxane Laboratories
14
Scope of the Claim
14
The Patent Box
14
Third-Party
14
Uniform Trade Secrets Acts
14
Video Games
14
Wireless Technology
13
Abuse of Dominance
13
Arbitration Agreements
13
Assignment of Inventions
13
Assignments
13
Cephalon
13
Covenant Not to Sue
13
Document Productions
13
Ex Parte
13
Federal Jurisdiction
13
Filing Requirements
13
Financial Institutions
13
Ford Motor
13
Grace Period
13
Investigations
13
Investors
13
Italy
13
Joint Inventors
13
McRo v Bandai Namco
13
Mobile Apps
13
Nanotechnology
13
Precedential Opinion
13
Prior User
13
Public Use
13
Reviewability Determinations
13
Separation of Powers
13
Star Athletica v Varsity Brands
13
Supplementary Protection Certificate
13
Waivers
12
Admissible Evidence
12
Amended Complaints
12
Animation
12
Antitrust Division
12
Contract Terms
12
Corporate Taxes
12
CRISPR
12
Data Collection
12
Divisional Applications
12
Domain Names
12
Dow Chemical
12
Drug Pricing
12
Electronics
12
Failure To State A Claim
12
Federal Contractors
12
Final Rules
12
Jury Trial
12
Miniauction
12
Nokia
12
Paid Time Off (PTO)
12
Patentability Search
12
Petitions for Review
12
Pre-GATT
12
Profits
12
Public Interest
12
Public Property
12
Ratification
12
Res Judicata
12
RICO
12
Right of Publicity
12
SIPO
12
Social Media
12
SSO
12
Supplemental Examination
12
Suppliers
12
Versata
11
Apportionment
11
Boehringer
11
Claim Preclusion
11
Compliance
11
Compulsory Licenses
11
Demand Letter
11
Disclaimers
11
Expiration Date
11
Fair Use
11
FDCA
11
Federal Pilot Programs
11
Garmin International
11
Gunn v Minton
11
Health Care Providers
11
IEEE
11
Information Disclosure Statement
11
Injury-in-Fact
11
Interference Claims
11
IPO
11
Legislative Committees
11
LG Electronics
11
Mandamus Petitions
11
Manufacturer Liability
11
Marvel Comics
11
Misrepresentation
11
Motion to Exclude
11
Nexus
11
Nvidia
11
Patent Amendments
11
PMNOC Regulations
11
Presumption of Validity
11
Price-Fixing
11
Registration
11
SAS Institute Inc. v Lee
11
Section 103
11
Sony
11
State Law Claims
11
Sua Sponte
10
Affordable Care Act
10
AIPLA
10
Anti-Dumping Duty
10
Antitrust Investigations
10
Applications
10
AT&T Mobility
10
Clinical Trials
10
Copyright Office
10
Customs and Border Protection
10
Dell
10
Doctrine of Prosecution Disclaimer
10
Electronic Data Transmissions
10
Expedited Actions Process
10
Extrinsic Evidence
10
Farms
10
Food Labeling
10
Foreign Jurisdictions
10
France
10
Fresenius
10
Highmark
10
Holidays
10
IBM
10
Intel
10
Joint Venture
10
Kraft
10
Licensing Rights
10
Limitation Periods
10
Medical Research
10
Motion for Reconsideration
10
Motion for Sanctions
10
Native American Issues
10
PHRMA
10
Physicians
10
Product Labels
10
Rule-of-Reason Analysis
10
Rulemaking Process
10
SAP America Inc.
10
Split of Authority
10
Supply Chain
10
Transparency
10
USTR
10
UTSA
10
Wearable Technology
9
Algorithms
9
Anti-Monopoly
9
Anticipatory Reference
9
Asset Seizure
9
Barnes and Noble
9
Brazil
9
Continuing Legal Education
9
Copyright Litigation
9
Cross-Licensing Agreement
9
DDR Holdings v Hotels.com
9
Discovery Disputes
9
Duty of Candor
9
False Claims Act (FCA)
9
FCPA
9
Federal Rules of Evidence
9
Follow-On Patent Petitions
9
General Electric
9
Hana Financial v Hana Bank
9
Indemnification
9
India
9
International Harmonization
9
JPO
9
Mediation
9
Motion for Judgment
9
Motion to Terminate
9
MPEP
9
NAFTA
9
National Cancer Moonshot
9
New Trial
9
OECD
9
Oracle
9
Order to Stay
9
OTDP
9
Parallel Claims
9
Patent Law Treaty
9
Privity of Contract
9
Product Exclusivity
9
Rebuttable Presumptions
9
Reversible Error
9
Salesforce
9
Sanofi-Aventis
9
Scientific Research
9
Supplemental Information
9
Terminal Disclaimer
9
Time Extensions
9
Trade Agreements
9
Treatment Method Patents
9
Tribal Governments
9
Twitter
9
Work Product Privilege
8
Abbott Laboratories
8
Alien Tort Statute
8
Amgen v Hospira
8
Anticompetitive Agreements
8
Arbitration Awards
8
Audits
8
B&B Hardware v Hargis Industries
8
Cartels
8
Celltrion
8
Cheerleaders
8
Clear and Convincing Evidence
8
Collaboration
8
Commercial General Liability Policies
8
Community Designs
8
Competition Authorities
8
DaimlerChrysler v Bauman
8
Databases
8
Declaratory Relief
8
Determination on Remand
8
Digital Media
8
Disgorgement
8
Economic Espionage Act
8
Effective Filing Date
8
Federal Arbitration Act
8
Form 18
8
Genzyme
8
GMO
8
Graham Factors
8
Graphical User Interface
8
gTLD
8
Health Canada
8
Health Insurance
8
Hewlett-Packard
8
Hiring & Firing
8
Hospitals
8
Huawei
8
Insurance Industry
8
Intellectual Property Owners Association
8
Janssen v Celltrion
8
JPMorgan Chase
8
Jury Awards
8
Mexico
8
Minimum Contacts
8
Motions in Limine
8
Music
8
Nike
8
Obama Administration
8
Objective Unreasonableness Standard
8
Online Gaming
8
Paris Convention
8
Premerger Notifications
8
Private Right of Action
8
Prometheus
8
Renewable Energy
8
Securities Fraud
8
Shire Development v Watson
8
Singapore
8
Solicitor General
8
Subsidiaries
8
Symantec
8
Tacking
8
Theft
8
Time-Barred Claims
8
Tortious Interference
8
Toshiba
8
Toyota
8
Walker Process Claims
8
White Collar Crimes
8
YouTube
7
ACIP
7
Administrative Appeals
7
Agency Deference
7
Amgen v Sandoz
7
Analogous Art
7
Article 50 Treaty of the EU
7
Asia
7
AT&T
7
Banks
7
BEPS
7
Big Data
7
Biogen Idec
7
Blackberry
7
Blockchain
7
Classen Immunotherapies
7
Connected Cars
7
Continuation Applications
7
Contract Interpretation
7
Countervailing Duties
7
Cybor Corp v FAS Technologies
7
Daubert Standards
7
Deadlines
7
Delays
7
Digital Health
7
Dismissal With Prejudice
7
Draft Guidance
7
Driverless Cars
7
Emerging Growth Companies
7
Encryption
7
Equitable Relief
7
Ericsson
7
European Union Trade Mark (EUTM)
7
Final Action
7
Financial Products
7
Forum Non Conveniens
7
FSIA
7
FTAIA
7
Function-Way-Result Test
7
Garmin Factors
7
Genuine Issue of Material Fact
7
Hearsay
7
Inducement
7
Inherent Disclosure Doctrine
7
Initial Determination (ID)
7
Internet of Things
7
Internet Service Providers (ISPs)
7
Internet Streaming
7
Japan Patent Office
7
Judges
7
KIPO
7
Korea
7
Labeling
7
Legal History
7
March-in
7
MOFCOM
7
Multinationals
7
Music Industry
7
New Regulations
7
NIH
7
Noerr-Pennington Doctrine
7
Novelty
7
Opt-Outs
7
Patent Re-Examination
7
Patented Medicine Prices Review Board (PMPRB)
7
PLTIA
7
Preamble
7
Primary Residence
7
Putative Class Actions
7
Raising The Bar Act
7
Reasonable Certainty Standard
7
Regulatory Oversight
7
Retailers
7
Rule 36
7
Rules of Practice
7
Section 112
7
Securities
7
South Korea
7
Statistical Analysis
7
Supply Contracts
7
Swiss Style Claims
7
Target
7
Tariffs
7
Technology Transfer Agreements
7
Tesla
7
The Clayton Act
7
Transfers
7
Trials
7
U.S. Commerce Department
7
UK Supreme Court
7
Unified Patent System
7
Uniforms
7
Unjust Enrichment
7
USDA
7
Warner Chilcott
7
Whistleblowers
7
WildTangent v Ultramercial
7
Willful Misconduct
7
Wyeth
6
Administrative Authority
6
Airlines
6
Amended Regulation
6
AOL
6
Artificial Intelligence
6
Banking Sector
6
Bankruptcy Code
6
Best Practices
6
Bitcoin
6
Canadian Intellectual Property Office
6
Case Consolidation
6
Class Certification
6
Coherus
6
Common-Interest Privilege
6
Computer Fraud and Abuse Act (CFAA)
6
Concurrent Litigation
6
Conflicts of Interest
6
Consent Order
6
Contempt
6
Coopertive Patent Classification System
6
Copyrightable Subject Matter
6
Court of Federal Claims
6
Criminal Prosecution
6
Deceptive Intent
6
Duty to Defend
6
eBay Test
6
Educational Institutions
6
EEA
6
Electronic Filing
6
Electronic Frontier Foundation
6
Email
6
Enhanced Penalties
6
Evidentiary Rulings
6
Exclusions
6
Exclusivity
6
Expedited Approval Process
6
False Marking
6
Federal Question Jurisdiction
6
Fiduciary Duty
6
Film Industry
6
Forum
6
Forward Publishing
6
GAO
6
Grable Factors
6
Honeywell International
6
Improper Venue
6
Insider Trading
6
International Searching Authority
6
International Treaties
6
Intervenors
6
IPEC
6
IRS
6
Jazz Pharmaceuticals
6
Judge Rakoff
6
Local Patent Rules
6
Local Rules
6
Marijuana
6
Memorandum of Guidance
6
Nexium
6
NLRB
6
NVIDIA Factors
6
Online Videos
6
Otsuka Pharmaceutical
6
Patent-Misuse
6
Petition for Review
6
Pharmacies
6
Prejudgment Interest
6
Prioritized Examination
6
Priority Date Cutoff
6
Privacy Laws
6
Private Sales
6
Public Policy
6
Redskins
6
Removal
6
Reputational Injury
6
Retail Market
6
Reverse Payments
6
Roslin
6
Rules of Civil Procedure
6
Russia
6
Sanofi
6
Scams
6
Scienter
6
Social Networks
6
Specific Jurisdiction
6
Sports
6
Standard Setting Organizations
6
State of Residency
6
State Universities
6
Strategic Planning
6
Subpoenas
6
Sunrise Periods
6
T-Mobile
6
Tax Incentives
6
Tax Rates